Circulating 11β-hydroxysteroid dehydrogenase type 1 mRNA and cardiovascular risk factors

Annals of the New York Academy of Sciences

Volumn 1137, Issue , 2008, Pages 283-289

  Al Bakir, Maise ^a   Butt, Asif N ^a   Swaminathan, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase type 1; Age; Alcohol; BMI; Menopause; mRNA; Smoking

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; CORTISONE; HYDROCORTISONE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; BODY MASS; CARDIOVASCULAR RISK; CONFERENCE PAPER; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; REGRESSION ANALYSIS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CORTISONE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; OBESITY; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; RNA, MESSENGER;

EID: 52249092649     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1448.007     Document Type: Conference Paper

References (24)

1. Peters, A.L. 2007. Identification of appropriate patients for cardiometabolic risk management. Rev. Cardiovasc. Med. 8 (Suppl 4 S9 16.
2. Tomlinson, J.W. & P.M. Stewart. 2005. Mechanisms of disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome. Nat. Clin. Pract. Endocrinol. Metab. 1 : 92 99.
3. Cope, C.L. & E. Black. 1958. The production rate of cortisol in man. Lancet 14 : 1020 1024.
4. Stewart, P.M. 1996. 11β-Hydroxysteroid dehydrogenase: implications for clinical medicine. Clin. Endocrinol. 44 : 493 499.
5. White, P.C. et al. 1997. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18 : 355 361.
6. Tomlinson, J.W. et al. 2004. 11β Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25 : 831 866.
7. Draper, N. & P.M. Stewart. 2005. 11β Hydroxysteroid dehydrogenase and pre-receptor regulation of corticosteroid hormone action. J. Endocrinol. 186 : 251 271.
8. Odermett, A. et al. 2006. Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11β-HSD1. Mol. Cell. Endocrinol. 248 : 15 23.
9. Bruley, C. et al. 2006. A novel promoter for the 11β-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPα independent. Endocrinology 147 : 2879 2885.
10. Carr, M.C. 2003. The emergence of metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 88 : 2404 2411.
11. Low, S.C. et al. 1993. Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J. Endocrinol. 139 : 27 35.
12. Gomez-Sanchez, E.P. et al. 2003. Regulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am. J. Physiol. Endocrinol. Metab. 285 : E272 E279.
13. Pepe, G.J. et al. 1999. Cloning of the 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-2 gene in the baboon: effects of estradiol on promoter activity of 11beta-HSD-1 and -2 in placental JEG-3 cells. Biochim. Biophys. Acta 1444 : 101 110.
14. Dieudonné, M.N. et al. 2006. Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99 : 189 196.
15. Bujalska, I.J. et al. 1997. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349 : 1210 1213.
16. Walker, B.R. & R. Andrew. 2006. Tissue production of cortisol by 11β-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann. N. Y. Acad. Sci. 1083 : 165 184.
17. Stewart, P.M. et al. 1999. Cortisol metabolism in human obesity: impaired cortisone to cortisol conversion in subjects with central adiposity. J. Clin. Endocrinol. Metab. 84 : 1022 1027.
18. Rask, E. et al. 2001. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Endocrinol. Metab. 86 : 1418 1421.
19. Rask, E. et al. 2002. Tissue specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 87 : 3330 3336.
20. Riddle, M.C. & P.A. McDaniel. 1993. Acute reduction of renal 11β-hydroxysteroid dehydrogenase activity by several anti-natriuretic stimuli. Metabolism 42 : 1370 1374.
21. Valentino, R. et al. 1995. Alcohol inhibits 11β-hydroxysteroid dehydrogenase activity in rat kidney and liver. Horm. Res. 43 : 176 180.
22. Zhang, Y et al. 2001. Effects of alcohol on blood pressure and production of vascular aldosterone and corticosterone. Horm. Res. 55 : 245 248.
23. Nammi, S. et al. 2006. Increased 11β-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 : R1101 R1109.
24. Maser E. et al. 2006. 11β-Hydroxysteroid dehydrogenase type 1: purification from the liver and characterization as carbonyl reductase of xenobiotics. Mol. Cell. Endocrinol. 24 : 34 37.